- Home
- UTSI vs CLDI Comparison
UTSI vs CLDI Comparison
Compare UTSI & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTSI
- CLDI
- Stock Information
- Founded
- UTSI 1991
- CLDI 2014
- Country
- UTSI China
- CLDI United States
- Employees
- UTSI N/A
- CLDI N/A
- Industry
- UTSI Telecommunications Equipment
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UTSI Telecommunications
- CLDI Health Care
- Exchange
- UTSI Nasdaq
- CLDI Nasdaq
- Market Cap
- UTSI 25.9M
- CLDI 22.3M
- IPO Year
- UTSI 2000
- CLDI N/A
- Fundamental
- Price
- UTSI $2.50
- CLDI $0.60
- Analyst Decision
- UTSI
- CLDI Strong Buy
- Analyst Count
- UTSI 0
- CLDI 2
- Target Price
- UTSI N/A
- CLDI $15.00
- AVG Volume (30 Days)
- UTSI 2.4K
- CLDI 433.2K
- Earning Date
- UTSI 04-11-2025
- CLDI 05-13-2025
- Dividend Yield
- UTSI N/A
- CLDI N/A
- EPS Growth
- UTSI N/A
- CLDI N/A
- EPS
- UTSI N/A
- CLDI N/A
- Revenue
- UTSI $10,878,000.00
- CLDI N/A
- Revenue This Year
- UTSI N/A
- CLDI N/A
- Revenue Next Year
- UTSI N/A
- CLDI N/A
- P/E Ratio
- UTSI N/A
- CLDI N/A
- Revenue Growth
- UTSI N/A
- CLDI N/A
- 52 Week Low
- UTSI $2.20
- CLDI $0.54
- 52 Week High
- UTSI $3.22
- CLDI $8.30
- Technical
- Relative Strength Index (RSI)
- UTSI 54.61
- CLDI 32.93
- Support Level
- UTSI $2.39
- CLDI $0.53
- Resistance Level
- UTSI $2.41
- CLDI $0.79
- Average True Range (ATR)
- UTSI 0.04
- CLDI 0.06
- MACD
- UTSI 0.02
- CLDI -0.01
- Stochastic Oscillator
- UTSI 100.00
- CLDI 14.29
About UTSI UTStarcom Holdings Corp.
UTStarcom Holdings Corp operates as a telecom infrastructure provider. It develops technology for bandwidth from cloud-based services, mobile, streaming, and other applications. The range of solutions is designed to expand and modernize telecommunications networks through smooth network system integration, lower operating costs, and increased broadband access. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. The company operates in China, India, Japan, Taiwan and other countries.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.